Novel Erythropoiesis Stimulating Protein (NESP) for the Treatment of Anaemia of Chronic Disease Associated With Cancer

British Journal of Cancer - United Kingdom
doi 10.1054/bjoc.2001.1749
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Anemia Treatment With Q2W Darbepoetin Alfa in Patients With Chronic Kidney Disease Naïve to Erythropoiesis-Stimulating Agents

Current Medical Research and Opinion
Medicine
2008English

Erythropoiesis-Stimulating Agents Increase the Risk of Acute Stroke in Patients With Chronic Kidney Disease

Kidney International
Nephrology
2011English

Management of Cancer-Associated Anemia With Erythropoiesis-Stimulating Agents: ASCO/ASH Clinical Practice Guideline Update

Journal of Oncology Practice
Health PolicyOncology
2019English

Characterization of the Anaemia Associated With Graves’ Disease

Clinical Endocrinology
EndocrinologyMetabolismDiabetes
2009English

PCN34 Cost Analysis of Anemia Treatment With Erythropoiesis-Stimulating Agents (ESAs) in Cancer Patients Receiving Chemotherapy in Italy

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

Effects of Anemia Correction by Erythropoiesis-Stimulating Agents on Cardiovascular Function in Non-Dialysis Patients With Chronic Kidney Disease

International Heart Journal
MedicineCardiovascular MedicineCardiology
2012English

The Effect of Pentoxifylline on Oxidative Stress in Chronic Kidney Disease Patients With Erythropoiesis-Stimulating Agent Hyporesponsiveness: Sub-Study of the HERO Trial

Redox Report
BiochemistryClinical BiochemistryCell BiologyPhysiology
2016English

Iron Repletion Is Associated With Reduction in Platelet Counts in Non-Dialysis Chronic Kidney Disease Patients Independent of Erythropoiesis-Stimulating Agent Use: A Retrospective Cohort Study

BMC Nephrology
Nephrology
2014English

Megaloblastic Anaemia Associated With Sulphasalazine Treatment.

BMJ
1977English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy